Title | Type | SJR | H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Nature Reviews Drug Discovery | journal | 9.483 Q1 | 391 | 255 | 680 | 8914 | 6743 | 350 | 9.02 | 34.96 | |
2 | Trends in Pharmacological Sciences | journal | 4.586 Q1 | 244 | 93 | 284 | 7123 | 3018 | 250 | 9.24 | 76.59 | |
3 | Natural Product Reports | journal | 3.552 Q1 | 211 | 65 | 214 | 9801 | 2304 | 208 | 10.66 | 150.78 | |
4 | Journal for ImmunoTherapy of Cancer | journal | 3.337 Q1 | 117 | 150 | 269 | 6491 | 1982 | 241 | 8.01 | 43.27 | |
5 | Neuropsychopharmacology | journal | 3.205 Q1 | 249 | 318 | 906 | 16743 | 5824 | 836 | 6.47 | 52.65 | |
6 | npj Vaccines | journal | 2.527 Q1 | 47 | 51 | 50 | 2652 | 236 | 48 | 4.72 | 52.00 | |
7 | Protein and Cell | journal | 2.280 Q1 | 94 | 103 | 313 | 5758 | 1411 | 235 | 3.98 | 55.90 | |
8 | Drug Discovery Today | journal | 2.248 Q1 | 215 | 215 | 576 | 15826 | 4269 | 545 | 7.04 | 73.61 | |
9 | Journal of Antimicrobial Chemotherapy | journal | 2.139 Q1 | 221 | 569 | 1517 | 18751 | 6676 | 1291 | 4.38 | 32.95 | |
10 | Emerging Microbes and Infections | journal | 2.117 Q1 | 94 | 206 | 249 | 8902 | 1150 | 188 | 4.75 | 43.21 | |
11 | PharmacoEconomics | journal | 1.942 Q1 | 118 | 121 | 332 | 4808 | 1253 | 285 | 3.17 | 39.74 | |
12 | International Journal of Neuropsychopharmacology | journal | 1.846 Q1 | 125 | 138 | 406 | 7958 | 1857 | 395 | 4.21 | 57.67 | |
13 | Neuropharmacology | journal | 1.780 Q1 | 191 | 500 | 1254 | 37062 | 5581 | 1232 | 4.41 | 74.12 | |
14 | Environmental Pollution | journal | 1.673 Q1 | 301 | 1483 | 2523 | 88097 | 15679 | 2490 | 6.12 | 59.40 | |
15 | Journal of Psychopharmacology | journal | 1.672 Q1 | 135 | 138 | 426 | 8170 | 1978 | 401 | 4.03 | 59.20 | |
16 | Particle and Fibre Toxicology | journal | 1.661 Q1 | 119 | 47 | 153 | 3157 | 1082 | 149 | 7.03 | 67.17 | |
17 | Human Genomics | journal | 1.632 Q1 | 68 | 50 | 102 | 2573 | 336 | 97 | 2.58 | 51.46 | |
18 | Nanotoxicology | journal | 1.617 Q1 | 107 | 77 | 364 | 4351 | 2308 | 355 | 6.44 | 56.51 | |
19 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.606 Q1 | 99 | 21 | 54 | 2386 | 347 | 51 | 6.40 | 113.62 | |
20 | Expert Review of Vaccines | journal | 1.603 Q1 | 105 | 102 | 358 | 8283 | 1412 | 327 | 4.12 | 81.21 | |
21 | BioDrugs | journal | 1.601 Q1 | 79 | 60 | 128 | 3632 | 663 | 124 | 5.11 | 60.53 | |
22 | British Journal of Clinical Pharmacology | journal | 1.530 Q1 | 167 | 315 | 866 | 11637 | 3241 | 741 | 3.51 | 36.94 | |
23 | Clinical Pharmacokinetics | journal | 1.529 Q1 | 184 | 119 | 340 | 6974 | 1545 | 311 | 4.47 | 58.61 | |
24 | Therapeutic Advances in Neurological Disorders | journal | 1.521 Q1 | 68 | 80 | 111 | 4715 | 476 | 102 | 3.89 | 58.94 | |
25 | Expert Opinion on Therapeutic Targets | journal | 1.470 Q1 | 106 | 91 | 359 | 9798 | 1568 | 333 | 4.30 | 107.67 | |
26 | Expert Opinion on Drug Discovery | journal | 1.450 Q1 | 84 | 104 | 305 | 9362 | 1451 | 283 | 4.09 | 90.02 | |
27 | Critical Reviews in Toxicology | journal | 1.442 Q1 | 129 | 48 | 112 | 5971 | 594 | 109 | 4.19 | 124.40 | |
28 | Drug Safety | journal | 1.438 Q1 | 140 | 132 | 324 | 4868 | 1211 | 273 | 3.30 | 36.88 | |
29 | Addictive Behaviors | journal | 1.418 Q1 | 149 | 415 | 903 | 18255 | 3040 | 893 | 3.18 | 43.99 | |
30 | Clinical Trials | journal | 1.417 Q1 | 74 | 80 | 275 | 2302 | 528 | 219 | 1.88 | 28.78 | |
31 | Current Opinion in Systems Biology | journal | 1.417 Q1 | 34 | 74 | 119 | 4679 | 231 | 106 | 1.94 | 63.23 | |
32 | Expert Opinion on Drug Delivery | journal | 1.337 Q1 | 133 | 96 | 399 | 9346 | 2201 | 375 | 5.18 | 97.35 | |
33 | Clinical Toxicology | journal | 1.298 Q1 | 108 | 175 | 429 | 3619 | 1281 | 288 | 3.03 | 20.68 | |
34 | Toxicological Sciences | journal | 1.280 Q1 | 207 | 309 | 753 | 15526 | 3225 | 704 | 3.58 | 50.25 | |
35 | Journal of Nanobiotechnology | journal | 1.255 Q1 | 109 | 100 | 260 | 6229 | 1525 | 257 | 5.57 | 62.29 | |
36 | F1000Research | journal | 1.235 Q1 | 105 | 793 | 1677 | 38678 | 5083 | 1595 | 3.25 | 48.77 | |
37 | Acta Pharmacologica Sinica | journal | 1.224 Q1 | 117 | 189 | 460 | 10647 | 1838 | 454 | 3.81 | 56.33 | |
38 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.177 Q1 | 106 | 65 | 242 | 2842 | 780 | 236 | 3.10 | 43.72 | |
39 | Mutagenesis | journal | 1.164 Q1 | 102 | 41 | 218 | 1720 | 729 | 215 | 3.02 | 41.95 | |
40 | Expert Opinion on Biological Therapy | journal | 1.133 Q1 | 102 | 154 | 460 | 11044 | 1661 | 435 | 3.58 | 71.71 | |
41 | CNS Neuroscience and Therapeutics | journal | 1.122 Q1 | 91 | 137 | 352 | 7603 | 1071 | 290 | 3.00 | 55.50 | |
42 | Pharmacogenomics Journal | journal | 1.096 Q1 | 95 | 93 | 230 | 4259 | 833 | 226 | 3.42 | 45.80 | |
43 | EPMA Journal | journal | 1.085 Q1 | 52 | 34 | 86 | 2395 | 393 | 83 | 4.87 | 70.44 | |
44 | Expert Opinion on Investigational Drugs | journal | 1.076 Q1 | 117 | 94 | 395 | 7440 | 1303 | 376 | 3.61 | 79.15 | |
45 | Molecular Diagnosis and Therapy | journal | 1.069 Q1 | 68 | 62 | 168 | 4756 | 486 | 163 | 3.16 | 76.71 | |
46 | Pharmacology Research and Perspectives | journal | 1.042 Q1 | 43 | 71 | 261 | 2645 | 682 | 256 | 2.60 | 37.25 | |
47 | Statistics in Biopharmaceutical Research | journal | 1.033 Q1 | 25 | 36 | 122 | 855 | 119 | 112 | 0.94 | 23.75 | |
48 | Expert Opinion on Therapeutic Patents | journal | 1.018 Q1 | 88 | 78 | 326 | 6056 | 1139 | 320 | 3.76 | 77.64 | |
49 | Expert Opinion on Emerging Drugs | journal | 0.977 Q2 | 54 | 29 | 116 | 2879 | 361 | 108 | 3.05 | 99.28 | |
50 | Clinical and Translational Science | journal | 0.955 Q1 | 60 | 77 | 235 | 2521 | 602 | 210 | 3.46 | 32.74 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®